KEY HIGHLIGHTS
Q2 Results Live: Max Healthcare Profit Rises 1.9%
Max Healthcare Q2 Highlights (Consolidated, YoY)
Revenue rises 25.3% to Rs 1,707 crore versus Rs 1,363 crore.
Ebitda rises16.3% at Rs 451 crore versus Rs 387 crore.
Margin at 26.4% vs 28.4%.
Net profit up 1.9% at Rs 282 crore versus Rs 277 crore.
Q2 Results Live: CCL Products Profit Rises 22%
CCL Products Q2 Highlights (Consolidated, YoY)
Revenue up 21.5% to Rs 738.20 crore versus Rs 607.57 crore.
Net profit up 22% to Rs 73.95 crore versus Rs 60.86 crore.
Ebitda up 25% to Rs 137.08 crore versus Rs 109.91 crore.
Margin at 18.6% versus 18.1%.
Q2 Results Live: PB Fintech's Insurance Premium At Rs 5,450 Crore
Insurance Premium stood at Rs 5,450 Cr insurance. While new core online insurance premium was up 61%, new health and life insurance premium was up 69%.
Source: Press Release
Q2 Results Live: PB Fintech Profit Falls 15%
PB Fintech Q2 Highlights (Consolidated, QoQ)
Revenue up 15.5% to Rs 1,167.23 crore versus Rs 1,010.49 crore.
Net profit down 15% to Rs 50.98 crore versus Rs 59.98 crore.
Ebitda loss at Rs 7.79 crore versus Ebitda loss of Rs 39.25 crore.
Q2 Results Live: Mazagon Dock Pipeline Includes Scorpene Submarines
Potential order pipeline of Mazagon Dock includes additional Scorpene submarines.
ONGC offshore project will be executed at Rs 7,000-8,000 crore in over two years.
Current capacity of the company includes 11 submarines and 10 warships.
The company is currently executing six large platforms and some smaller vessels.
Source: Earnings Concall
Q2 Results Live: Mazagon Dock Revenue Growth Expected At 10-12% Year-On-Year
Mazagon Dock expects revenue growth of 10-12% year-over-year, the management said on Tuesday. The company also expects normalized PBT margins of 12-15% for new projects.
Expects to maintain margins in the second half of this fiscal around the margins in the first half of financial year 2025.
Source: Earnings Concall
Q2 Results Live: Mazagon Dock Has Two Deliveries Planned before Dec. 31
Mazagon Dock has two deliveries planned before Dec. 31 that include one submarine and potentially one destroyer ahead of schedule.
Delivery of a second frigate may slip to the next financial year, the management said on Tuesday.
No reversal of liquidated damages occurred in the second quarter of this fiscal.
Source: Earnings Concall
Q2 Results Live: Timken India Profit Falls 3%
Timken India Q2 Highlights (YoY)
Revenue up 10.4% to Rs 752.89 crore versus Rs 681.98 crore.
Net profit down 3% to Rs 89.95 crore versus Rs 93.05 crore.
Ebitda down 2% to Rs 133.35 crore versus Rs 135.51 crore.
Margin at 17.7% versus 19.9%.
Q2 Results Live: Sundram Fasteners Profit Rises 8%
Sundram Fasteners Q2 Highlights (Consolidated, YoY)
Revenue up 4.5% to Rs 1,486.04 crore versus Rs 1,421.82 crore.
Net profit up 8% to Rs 143.84 crore versus Rs 133.05 crore.
Ebitda up 6% to Rs 244.63 crore versus Rs 230.73 crore.
Margin at 16.5% versus 16.2%.
Q2 Results Live: Muthoot Microfin Profit Falls 43.7%
Muthoot Microfin Q2 Highlights (Consolidated, YoY)
Total income rises 18% at Rs 667 crore versus Rs 565 crore.
Net profit falls 43.7% at Rs 61.6 crore versus Rs 110 crore.
Q2 Results Live: eClerx Services Profit Rises 24%
eClerx Services Q2 Highlights (Consolidated, YoY)
Revenue up 6.4% to Rs 831.84 crore versus Rs 781.92 crore.
Net profit up 24% to Rs 139.50 crore versus Rs 112.05 crore.
Ebit up 36% to Rs 182.87 crore versus Rs 134.71 crore.
Margin at 22.0% versus 17.2%.
Q2 Results Live: Chemplast Sanmar Reports Loss Of Rs 31.26 Crore
Chemplast Sanmar Q2 Highlights (Consolidated, YoY)
Revenue up 0.5% to Rs 992.75 crore versus Rs 987.75 crore.
Net loss at Rs 31.26 crore versus Rs 26.05 crore.
Ebitda down 44% to Rs 25.80 crore versus Rs 45.95 crore.
Margin at 2.6% versus 4.7%.
Q2 Results Live: Triveni Engineering & Industries Reports Net Loss Of Rs 22.42 Crore
Triveni Engineering & Industries Q2 Highlights (Consolidated, YoY)
Revenue up 8.1% to Rs 1,490.95 crore versus Rs 1,408.84 crore.
Net loss at Rs 22.42 crore versus profit of Rs 29.11 crore.
Ebitda down 93% to Rs 4.64 crore versus Rs 62.93 crore.
Margin at 0.3% versus 4.5%.
Q2 Results Live: Oil India Profit Rises 3%
Oil India Q2 Highlights (Consolidated, QoQ)
Revenue down 13.0% to Rs 7,247.03 crore versus Rs 8,120.21 crore.
Net profit up 3% to Rs 2,069.16 crore versus Rs 2,016.30 crore.
Ebitda down 19% to Rs 2,535.83 crore versus Rs 3,141.95 crore.
Margin at 35.0% versus 38.7%.
Q2 Results Live: GAIL India Profit Falls 16%
GAIL India Q2 Highlights (Consolidated, QoQ)
Revenue down 2.4% to Rs 33,888.90 crore versus Rs 34,737.77 crore.
Net profit down 16% to Rs 2,689.67 crore versus Rs 3,183.35 crore.
Ebitda down 18% to Rs 3,937.20 crore versus Rs 4,790.02 crore.
Margin at 11.6% versus 13.8%.
Q2 Results Live: Waaree Renewable Technologies Profit Doubles At Rs 524.46 Crore
Waaree Renewable Technologies Q2 Highlights (Consolidated, YoY)
Revenue up 249.5% to Rs 524.46 crore versus Rs 150.06 crore.
Net profit up 161% to Rs 53.52 crore versus Rs 20.54 crore.
Ebitda up 133% to Rs 71.56 crore versus Rs 30.67 crore.
Margin at 13.6% versus 20.4%.
Q2 Results Live: Dr. Reddy's Laboratories North America Revenue Rose 9%
Dr. Reddy's Laboratories Europe revenue rose 9% year-on-year to Rs 5.8 billion on account of leveraging the portfolio to launch new products, partly offset by price erosion. Sequentially it rose 10% on the back of new product launches.
Europe's revenue in the first half rose 7% year-on-year to Rs 11 billion on account of new product launches and momentum in base business, partly offset by price erosion.
Source: Press Release
Q2 Results Live: Dr. Reddy's Laboratories North America Revenue Rose 17%
Dr. Reddy's Laboratories North America revenue rose 17% year-on-year to Rs 37.3 billion driven by improved sales volumes, partly offset by price erosion. Sequentially it fell 3% due to decrease in sales volume.
North America revenue in the first half rose 19% year-on-year to Rs 75.7 billion driven by increase in sales.
Source: Press Release
Q2 Results Live: Dr. Reddy's Laboratories Global Generics Revenue Rose 17%
Dr. Reddy's Laboratories global generics revenue rose 17% year-on-year to Rs 71.6 billion driven by improved sales volumes and new product launches. Sequentially it grew 4% with growth primarily driven by Emerging Markets and Europe.
Global generics revenue in the first half rose 16% year-on-year to Rs 14.04 crore driven by increase in sales across all markets.
Source: Press Release
Q2 Results Live: Titan Expects Second Half To Be Better
Titan expects the second half of this fiscal be better than the first half.
If the lab grown jewellery amount goes beyond Rs 1 lakh, customer interest drops significantly, the management said on Tuesday.
"Nothing is stopping us from entering lab grown diamond space, we have not launched it yet considering market trends - we will speak about it when its time," the management added.
Source: Earnings Concall
Q2 Results Live: Buyer Growth In Studded Jewellery Strong
Titan's buyer growth in the studded jewelley is strong the management said on Tuesday.
The company further added that the ticket size in gold has remained unchanged, while the ticket size in solitaire has been affected.
The company is keeping a close track on lab grown diamonds.
Margins in financial year 2025 to be in the range of 11-11.5%
Trent is a big retailer and has a diversified business, hence it makes sense for it to enter lab grown diamond space
Non solitaire diamonds demand remains unimpacted.
Source: Earnings Concall
Q2 Results Live: Dr. Reddy’s Laboratories To Invest Rs 600 Crore In Step-Down Arm
The board of Dr. Reddy’s Laboratories on Tuesday approved investment worth up to Rs 600 crore in Russia-based step-down arm.
Source: Exchange Filling
Q2 Results Live: Titan Margins Take A Hit Due To Custom Duty Loss
Titan margins have taken a hit on account of one-time custom duty loss partly in this quarter and partly in next quarter, lower studded mix and large carat solitaire diamond stone demand is affected to international demand supply pressure.
Source: Earnings Concall
Q2 Results Live: JK Tyre & Industries Profit Falls 44%
JK Tyre & Industries Q2 Highlights (Consolidated, YoY)
Revenue down 7.1% to Rs 3,621.56 crore versus Rs 3,897.53 crore.
Net profit down 44% to Rs 139.75 crore versus Rs 248.62 crore.
Ebitda down 28% to Rs 421.26 crore versus Rs 589.14 crore.
Margin at 11.6% versus 15.1%.
Q2 Results Live: Mankind Pharma Profit Rises 29%
Mankind Pharma Q2 Highlights (Consolidated, YoY)
Revenue up 13.6% to Rs 3,076.51 crore versus Rs 2,708.10 crore.
Net profit up 29% to Rs 658.88 crore versus Rs 511.18 crore.
Ebitda up 25% to Rs 850.04 crore versus Rs 682.65 crore.
Margin at 27.6% versus 25.2%.
Q2 Results Live: Berger Paints Profit Falls 8%
Berger Paints Q2 Highlights (Consolidated, YoY)
Revenue up 0.3% to Rs 2,774.61 crore versus Rs 2,767.30 crore.
Net profit down 8% to Rs 269.90 crore versus Rs 292.13 crore.
Ebitda down 8% to Rs 434.18 crore versus Rs 473.65 crore.
Margin at 15.6% versus 17.1%.
Q2 Results Live: Titan Watches And Wearables Revenue Rises 19%
Watches and wearables revenue of Titan rises 19% at Rs 1,304 crore versus Rs 1,092 crore.
Jewellery Revenue rises 15% to Rs 12,771 crore versus Rs 11,081 crore.
Eyecare Revenue rises 7% to Rs 202 crore versus Rs 189 crore.
Q2 Results Live: Titan Profit Falls 23%, Misses Estimates
Titan Q2 Highlights (Consolidated, YoY)
Revenue up 16.0% to Rs 14,534.00 crore versus Rs 12,529.00 crore.
Net profit down 23% to Rs 704.00 crore versus Rs 916.00 crore.
Ebitda down 12% to Rs 1,236.00 crore versus Rs 1,411.00 crore.
Margin at 8.5% versus 11.3%.
Q2 Results Live: Dr. Reddy’s Laboratories Profit Falls 9%
Dr. Reddy’s Laboratories Q2 Highlights (Consolidated, YoY)
Revenue up 16.5% to Rs 8,038.20 crore versus Rs 6,902.60 crore.
Net profit down 9% to Rs 1,341.90 crore versus Rs 1,482.20 crore.
Ebitda up 3% to Rs 2,076.50 crore versus Rs 2,008.30 crore.
Margin at 25.8% versus 29.1%.
Q2 Results Live: Datamatics Global Services Profit Falls 4%
Datamatics Global Services Q2 Highlights (Consolidated, QoQ)
Revenue up 3.2% to Rs 406.75 crore versus Rs 393.99 crore.
Net profit down 4% to Rs 42.20 crore versus Rs 43.82 crore.
Ebit down 8% to Rs 39.34 crore versus Rs 42.60 crore.
Margin at 9.7% versus 10.8%.
Q2 Results Live: Manappuram Finance Profit Rises 2%
Manappuram Finance Q2 Highlights (Consolidated, YoY)
Total income rises 21.3% at Rs 2,637 crore versus Rs 2,174 crore.
Net Profit up 2% at Rs 572 crore versus Rs 561 crore.
Q2 Results Live: SJVN Shares Rises Nearly 5%
Shares of SJVN gained 4.88% to Rs 116.85 apiece, before paring gains to trade 2.26% higher at Rs 113.93 by 3:12 p.m. after the company reported a 16.8% increase in revenue to Rs 1,026 crore. The benchmark NSE Nifty 50 was trading 0.91% higher.
The stock has risen 55.11% in the last 12 months and 22.55% on a year-to-date basis. The total traded volume so far in the day stood at 1.4 times its 30-day average. The relative strength index was at 43.
Three out of the five analysts tracking SJVN have a 'buy' rating on the stock, while one suggests a hold and one suggests a 'sell', according to Bloomberg data. The average of 12-month analyst price targets implies a potential downside of 14.7%.
Q2 Results Live: Ceigall India (Consolidated YoY)
Revenue up 4.2% At Rs 772 crore versus Rs 741 crore.
Ebitda down 2.8% at Rs 123 crore versus Rs 127 crore.
Margin at 15.9% versus 17.1%.
Net Profit down 11.4% at Rs 65.5 crore versus Rs 73.9 crore.
Q2 Results Live: SJVN (Consolidated YoY)
Revenue up 16.8% at Rs 1,026 crore versus Rs 878 crore.
Ebitda up 17.3% at Rs 828 crore versus Rs 706 crore.
Margin at 80.7% versus 80.4%.
Net profit up 0.1% at Rs 439.9 crore versus Rs 439.6 crore.
Q2 Results Live: Rane Holding (Consolidated YoY)
Revenue down 1.2% at Rs 917 crore versus Rs 928 crore.
Ebitda up 15.7% at Rs 81.2 crore versus Rs 70.2 crore.
Margin at 8.8% versus 7.6%.
Net profit at Rs 185 crore versus Rs 51 crore.
Q2 Results Live: Mazagon Dock Shares Up Nearly 7%
Shares of Mazagon Dock spiked as much as 7.23% to Rs 4318 apiece after the PSU reported a 75% uptick in net profit, beating estimates.
Q2 Results Live: Alkyl Amines (YoY)
Revenue up 17.8% at Rs 415 crore versus Rs 352 Cr
Ebitda up 52.4% at Rs 73.6 crore versus Rs 48.3 crore.
Margin at 17.7% versus 13.7%.
Net profit up 74.5% At Rs 47.5 crore versus Rs 27.2 crore.
Q2 Results Live: Mazagon Dock Profit Beat Estimates
Mazagon Dock Shipbuilders Q2 Highlights (Consolidated, YoY)
Revenue up 51% at Rs 2,757 crore versus Rs 1,828 crore.
Ebitda up 189% at Rs 511 crore verus Rs 177 crore.
Margin at 18.5% versus 9.7%.
Net profit up 76% at Rs 585 crore versus Rs 333 crore.
Q2 Results Live: KPR Mill Net Profit Rises Marginally
KPR Mill Q2 Highlights (Consolidated, YoY)
Revenue down 2.1% at Rs 1,480 crore versus Rs 1,511 crore.
Ebitda down 0.5% at Rs 296 crore versus Rs 298 crore.
Margin at 20% versus 19.7%.
Net profit up 1.5% at Rs 205 crore versus Rs 202 crore.
Q2 Results Live: Saregama India (Consolidated YoY)
Revenue up 40.3% at Rs 242 crore versus Rs 172 crore.
Ebitda flat at Rs 60.8 crore.
Margin at 25.1% versus 35.3%.
Net profit down 6.3% at Rs 44.9 crore versus Rs 47.9 crore.
Q2 Results Live: Market Check
Here's a market check on how the stocks posting their results are doing ahead of the announcement.
Most are trading in the red compared to a 0.49% decline in the benchmark Nifty 50 as of 12:33 p.m.
Q2 Results Live: Mankind Pharma Estimates
Mankind Pharma is expected to announce a net profit of Rs 600 crore, with revenue estimated at Rs 3,050 crore and an Ebitda of Rs 781 crore, reflecting a margin of 25.6%.
In the preceding quarter, Mankind Pharma had reported consolidated revenue from operations of Rs 2,893.42 crore, up 12.2% YoY. Net profit increased nearly 10% over the previous year to Rs 543.1 crore in Q1 compared to Rs 494.2 crore in the same quarter last year.
Q2 Results Live: Oil India Estimates
Oil India is likely to report a standalone net profit of Rs 1,933 crore and revenue of Rs 5,292 crore.
In its June quarter results, Oil India had exceeded analysts’ estimates in terms of consolidated net profit. The profit after tax, or net profit, fell 14% YoY in the first quarter to Rs 2,016.3 crore against Rs 2,332.94 crore in the June quarter of the preceding fiscal.
Q2 Results Live: Titan Company Estimates
Titan is expected to report a net profit of Rs 969 crore, with revenue projected at Rs 13,425 crore, as per analysts' consensus estimate compiled by Bloomberg. The company’s Ebitda is estimated at Rs 1,566 crore, resulting in an Ebitda margin of 11.7%.
In the first quarter, the company's consolidated profit-after-tax declined 5.5% year-on-year in the first quarter of financial year 2025 to Rs 715 crore versus Rs 756 crore in the year-ago period.
Titan Q1 FY25 Highlights (Consolidated, YoY)
Total income up 11.2% to Rs 12,308 crore versus Rs 11,069 crore.
Profit-after-tax down 5.5% to Rs 715 crore versus Rs 756 crore.
Ebitda up 10.3% to Rs 1,367 crore versus Rs 1,239 crore.
Ebitda margin at 11.1% versus 11.2%.
Q2 Results Live: Who's Posting Results Today
It’s shaping up to be a bustling day on the markets with 64 companies set to release their September quarter earnings results. As numbers roll in, we’ll be keeping an eye on the big players. Some of the top names in today's list are Titan Co., Oil India Ltd., Mazagon Dock Shipbuilders Ltd., SJVN Ltd., Mankind Pharma Ltd., and GAIL India Ltd.
So far, this earnings season has been disappointing with brokerages chiming in with downgrades on the back of excessive stock valuations in a correcting market.
RECOMMENDED FOR YOU
Q2 Results Updates: Grasim Industries Profit Falls 9%; Hero MotoCorp Profit Rises 14%
Nov 14, 2024
Q2 Results Updates: Dilip Buildcon Profit More Than Triples; Vodafone Net Loss Widens
Nov 13, 2024
Q2 Results Updates: Sula Vineyard Profit Falls 37%; Ashoka Buildcon Profit More Than Quadruples
Nov 12, 2024
Q2 Results Updates: Cummins Profit Rises 37%; NHPC Profit Misses Estimates
Nov 07, 2024
POPULAR